RIPK1-IN-16
RIPK1-IN-16 is an orally active and potent inhibitor of RIPK1. RIPK1-IN-16 inhibits excessive inflammation by blocking RIPK1-mediated necroptosis in vivo. RIPK1-IN-16 protects mouse from TNF-induced systemic inflammatory response syndrome and sepsis[1].
Product Specifications
CAS Number
[2561431-77-2]
UNSPSC
12352005
Target
RIP kinase
Type
Reference compound
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ripk1-in-16.html
Solubility
10 mM in DMSO
Smiles
CN1C2=CC=CC=C2OC[C@H](NC(C3=NNC(CC4=CC=CC=C4)=N3)=O)C1=S
Molecular Formula
C20H19N5O2S
Molecular Weight
393.46
References & Citations
[1]Ling ZY, et al. Protective Effect of a Novel RIPK1 Inhibitor, Compound 4-155, in Systemic Inflammatory Response Syndrome and Sepsis. Inflammation. 2023 Oct;46 (5) :1796-1809.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
NBP2-99791-100ul 100 µL
Rabbit Polyclonal Cytosolic Sulfotransferase 2A1/SULT2A1 Antibody
Ask
View Details MBS6269321-01 0.2 mL
14-3-3, gamma, ID (Protein Kinase C Inhibitor Protein 1, KCIP-1, 14-3-3 Protein gamma, N-terminally Processed, YWHAG) (Biotin)
Ask
View Details 
MBS6269321-02 5x 0.2 mL
14-3-3, gamma, ID (Protein Kinase C Inhibitor Protein 1, KCIP-1, 14-3-3 Protein gamma, N-terminally Processed, YWHAG) (Biotin)
Ask
View Details MBS2512153-01 24 Tests (Limit 1)
Monkey TSLP (Thymic Stromal Lymphopoietin) ELISA Kit
Ask
View Details 